|
(L1) 6501.70611-Anidulafungin, 100 Mg, Powder For Injectable Solution, Ampoule Vial, Route Of Administration: Intravenous, Units. Size: Unit, (L2) 6501.3158-Human Insulin Nph, 100 Iu/Ml, Injectable Suspension, 10 Ml, Route Of Administration: Subcutaneous, (L3) 6501.3160-Regular Human Insulin, Injectable Solution, (L4) 6501.1783-Rocuronium, Bromide, 10 Mg/Ml, 5 Ml, (L5) 6501.253-Ambroxol, Hydrochloride (Adult), 6 Mg/Ml, Syrup, Bottle, 100 To 120 Ml, Dosing Cup/Syringe, Route Of Administration: Oral, 07/11 /2023, (L6) 6501.2681-Cabergoline, 0.5 Mg, Tablet, Blister, (L7) 6502.1033-Carbamazepine, 400 Mg, Ordinance 344/98: C1, (L8) 6501.312-Carvedilol, 12, (L9) 6501.326- Ketoconazole, 20 Mg/G (2%), Dermatological Cream, Tube, 30 G, Route Of Administration: Topical, (L10) 6501.2693-Cilostazol, 50 Mg, (L11) 6502.2697-Citalopram, Hydrobromide, 20 Mg, Coated Tablet, (L12) 6501.57939-Collagenase, 1, 2 U/G, Dermatological Ointment, Route Of Administration: Dermatological, (L13) 6501.583-Diltiazem, Hydrochloride, 60 Mg, (L14) 6501.2739-Doxazosin, Mesylate, 4Mg, (L15) 6501.748 -Enalapril, Maleate, (L16) 6501.2557-Dibasic Sodium Phosphate + Monobasic Sodium Phosphate, 06 + 0, 16 G/Ml, Enema, Applicator Bottle, 100 To 133 Ml, Route Of Administration: Rectal, (L17) 6523.59349- Glycerin Suppository (Glycerol), Is A Laxative Indicated In The Treatment And/Or Prevention Of Constipation And Has The Purpose Of Causing Bowel Movements, A Product Registered With Anvisa/Ms, The Characteristics Of The Packaging Must Comply With Specific Abnt Standards E Ms, Brand: Undetermined Box 6, 12 Or 24 Units, Packaging: Individual, Additional Features: Service For Court Order (According To Medical Prescription), (L18) 6501.3911-Loratadina, 1 Mg/Ml, 100 Ml, (L19) 6501.62424 -Nystatin+Zn Oxide, 100000Ui/G+200Mg/G, Ointment, Tube, 60 G, Units. Size: Tube, (L20) 6501.1381-Zinc Oxide + Retinol (Vitamin A) + Cholecalciferol (Vitamin D), 150 Mg + 5,000 Iu + 900 Iu/G, 45 G
|
